this is a bit different - chamelion were holding up the 325 mil deal - Premar have no such leverage and i doubt their legal case is strong.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025